Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 318NIH 82INDUSTRY 72NETWORK 43OTHER_GOV 4UNKNOWN 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 21Stomach Neoplasms 14Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Rectal Neoplasms 7Triple Negative Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 4Lymphoma, Extranodal NK-T-Cell 4Esophageal Squamous Cell Carcinoma 4Esophageal Neoplasms 4Brain Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Head and Neck Neoplasms 3Vomiting 2Sarcoma 2Recurrence 2Nasopharyngeal Carcinoma 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2HER2-positive Breast Cancer 2Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Lung 1Radiation Injuries 1Platinum-resistant Recurrent Ovarian Cancer 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pain 1Ovarian Neoplasms 1

Interventions

endostar protein 1camrelizumab 1apatinib 1Gemcitabine 1Endostatins 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × UNKNOWN × Sarcoma × Clear all
NCT04447274 2020-06-25

A Study of Carilizumab in Combination With Apatinib in Subjects With Unresectable UPS and ASPS

ChineseAMS

Phase 2 Unknown
20 enrolled
Sarcoma

Sarcoma

NCT01812018 2013-03-15

Endostar + GT in Pulmonary Metastases of Soft Tissue Sarcoma

ChineseAMS

Phase 2 Unknown
30 enrolled
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡